Durability of clinical benefit and biomarkers in patients with advanced non-small cell lung cancer (NSCLC) treated with sotorasib, a KRAS(G12C) inhibitor Meeting Abstract


Authors: Hong, D. S.; Bang, Y. J.; Barlesi, F.; Durm, G.; Falchook, G.; Govindan, R.; Dy, G.; Park, K.; Strickler, J.; Burns, T.; Kim, J.; Ang, A.; Lipford, J. R.; Ngarmchamnanrith, G.; Anderson, A.; Li, B. T.
Abstract Title: Durability of clinical benefit and biomarkers in patients with advanced non-small cell lung cancer (NSCLC) treated with sotorasib, a KRAS(G12C) inhibitor
Meeting Title: 2020 North America Conference on Lung Cancer
Journal Title: Journal of Thoracic Oncology
Volume: 16
Issue: 1 Suppl.
Meeting Dates: 2020 Oct 16-17
Meeting Location: Virtual
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2021-01-01
Start Page: S28
End Page: S29
Language: English
ACCESSION: WOS:000610079600058
PROVIDER: wos
DOI: 10.1016/j.jtho.2020.10.136
Notes: Meeting Abstract: MO01.31 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Bob Tingkan Li
    279 Li